Creative Planning’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Creative Planning’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,500	Closed	-$134K	–	4801
2016 Q1	$134K	Sell	2,500 -18	-0.7%	-$1.33K	﹤0.01%	1458
2015 Q4	$284K	Buy	2,518 +591	+31%	+$65.1K	﹤0.01%	1023
2015 Q3	$227K	Buy	+1,927	New	+$252K	﹤0.01%	1126
2015 Q2	–	Sell	-3,300	Closed	-$191K	–	4318
2015 Q1	$191K	Buy	3,300 +300	+10%	+$12.7K	﹤0.01%	1211
2014 Q4	$97K	Buy	+3,000	New	+$90.1K	﹤0.01%	1566

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Creative Planning's ANAC Position: Q2 2016 in Review

Creative Planning sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 2,500 shares — an estimated $134K sold.

Creative Planning first reported a position in ANAC in Q4 2014 and held it in 5 quarters. The position peaked at $284K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Creative Planning reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Creative Planning sold 2,500 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $134K.
Creative Planning first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 5 quarters.
Creative Planning's ANACOR PHARMACEUTICALS INC COM position peaked at $284K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Creative Planning's 13F filing for Q2 2016, filed 12 Jul 2016.